Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v29-FR Version v13-FR
Language French French
Date Updated 2019-03-08 2018-12-10
Drug Identification Number 02216167 02216167
Brand name IMOVANE IMOVANE
Common or Proper name IMOVANE 5MG TB BTX100 IMOVANE 5MG TB BTX100
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients ZOPICLONE ZOPICLONE
Strength(s) 5.0MG 5.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N05CF N05CF
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2018-04-27 2018-04-27
Actual start date 2018-04-27 2018-04-27
Estimated end date 2019-03-08 2019-02-15
Actual end date 2019-03-07
Shortage status Resolved Actual shortage
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments